Neurocysticercosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Neurocysticercosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT00001205

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

Neurocysticercosis is a brain disease due to the larval stage of the pork tapeworm (Taenia solium). The most common symptoms patient experience from infection i…

United States500 participantsStarted 1985-10-07

All recent trials (31 shown)

Not Yet RecruitingPhase 2/3

NCT06565507

Oxfendazole in Mild Parenchymal Brain Cysticercosis

The goal of this clinical trial is to compare a single and multiple dose regimens of oxfendazole with the standard treatment in patients with mild (one or two l…

Location not specified544 participantsStarted 2026-12-01

Treatment: Oxfendazole single dose, Oxfendazole three doses

Not Yet RecruitingNot Applicable

NCT07208656

The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis

This randomized controlled trial evaluates whether exposure to a medical television drama improves knowledge of neurocysticercosis (NCC) among young adults. Six…

Location not specified60 participantsStarted 2025-12-15

Treatment: Medical TV Drama Episode (House M.D.)

Neurocysticercosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

All recent trials (31 shown)

Oxfendazole in Mild Parenchymal Brain Cysticercosis

The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

All recent trials (31 shown)

Oxfendazole in Mild Parenchymal Brain Cysticercosis

The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis

Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

Treatment of Patients With Active Neurocysticercosis in Eastern Africa

Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia

The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania

Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?

Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)

SANCC: Clinical Trial Early Intervention

Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature Review

Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study

Digital Health Promotion in Iringa, Tanzania

Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole

Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in Poland

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28

RCT ALB for SA Cysticercosis

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB

People Presenting With Neurocysticercosis in North America

EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso